Title:
TRUNCATED RESPIRATORY SYNCYTIAL VIRUS F PROTEIN AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2024/082681
Kind Code:
A1
Abstract:
Provided are a fusion protein, and a nucleic acid molecule comprising a nucleotide sequence encoding the fusion protein. The present invention also relates to a vaccine comprising the fusion protein or the nucleic acid molecule. Furthermore, the present invention also relates to a method for preventing and/or treating RSV infections or diseases and/or symptoms caused by RSV infections by means of using the fusion protein, the nucleic acid molecule and the vaccine.
Inventors:
ZHENG ZIZHENG (CN)
LIN MIN (CN)
YIN YIFAN (CN)
WANG CHEN (CN)
ZHAO XIAOMENG (CN)
CHEN LI (CN)
ZHANG JUN (CN)
XIA NINGSHAO (CN)
LIN MIN (CN)
YIN YIFAN (CN)
WANG CHEN (CN)
ZHAO XIAOMENG (CN)
CHEN LI (CN)
ZHANG JUN (CN)
XIA NINGSHAO (CN)
Application Number:
PCT/CN2023/102342
Publication Date:
April 25, 2024
Filing Date:
June 26, 2023
Export Citation:
Assignee:
XIAMEN UNIV (CN)
XIAMEN INNOVAX BIOTECH CO LTD (CN)
XIAMEN INNOVAX BIOTECH CO LTD (CN)
International Classes:
C07K19/00; A61K39/155; C07K16/10; C12N15/62; C12N15/86; C12Q1/02; G01N33/569; G01N33/68
Attorney, Agent or Firm:
CCPIT PATENT AND TRADEMARK LAW OFFICE (CN)
Download PDF: